Development of a nomogram for predicting recurrence of epithelial ovarian cancer involving traditional Chinese medicine treatment
The nomogram we developed effectively predicted 2-year recurrence risk in epithelial ovarian cancer patients. Notably, TCM treatment lasting more than 6 months may help prolong progression-free survival (PFS).
Authors
- Huanmei Lin
- Hongmei Ouyang
- Bo Gao (ORCID: https://orcid.org/0000-0003-2818-4000)
- Xudong Hu (ORCID: https://orcid.org/0000-0002-2166-0564)
- Xiangdan Hu
- Xiaofeng Chen (ORCID: https://orcid.org/0000-0001-8872-8028)
- Ziang Li (ORCID: https://orcid.org/0000-0002-2148-8530)
- Jing Xiao (ORCID: https://orcid.org/0000-0002-9953-5878)
Institutions
- Guangzhou University of Chinese Medicine (CN)
- Guangdong Provincial Hospital of Traditional Chinese Medicine (CN)
- Guangdong Province Women and Children Hospital (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-05-08
- DOI
- https://doi.org/10.3389/fonc.2025.1577110
- Citations
- 1
- Primary Topic
- Ovarian cancer diagnosis and treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.70
Funders
- Guangdong Provincial Hospital of Traditional Chinese Medicine
- National Natural Science Foundation of China